P2B-098

State Healthcare Institution "Republican Clinical Oncological Center of the Ministry of Health of Republic of Tatarstan" (Kazan', Russia) › P2B-098

P2B-098

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Healthcare Institution "Republican Clinical Oncological Center of the Ministry of Health of Republic of Tatarstan" (Kazan', Russia) · Dr. Clarke
consented 2013-04-08

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 fatigue with onset in cycle 3 (2013-06-17); assessed as related to study drug (possible); resolved 2013-06-24.

moderate assessed

Grade 3 pain in extremity with onset in cycle 1 (2013-04-30); assessed as not related to study drug (not related); resolved 2013-05-17.

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.